Medical image software developer Subtle Medical has been granted the CE Mark for the second generation of its SubtlePET software, which removes noise to improve low-count PET image quality.
Also, the software now can be used with radiopharmaceuticals that target prostate-specific membrane antigen (PSMA) expression and neuroendocrine tumors. The software is vendor-neutral and can be used with any company's PET and PET/CT equipment.
